Bringing Cure...Building Hope...
Home | Blog | Events
Pharma legitimate consultant and facilitator in Delhi India

DUPIXENT (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017. Available In India

Dupilumab, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis. DUPIXENT (dupilumab) injection can be imported for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Generic Name: dupilumab Brand Name: DUPIXENT
DUPIXENT (dupilumab) injection is used for used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis.

Therapeutic indications and Usage Atopic Dermatitis: for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.
Asthma: as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus.
Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP): as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis.
Eosinophilic Esophagitis: for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis (EoE). Prurigo Nodularis: for the treatment of adult patients with prurigo nodularis (PN).
Medicine Name: DUPIXENT
Generic Name: dupilumab
Approval Date: 2017
Treatment of: atopic dermatitis (eczema).
Company Name: Regeneron Pharmaceuticals, Inc.
Source Details: Patient Information

Patient Name Basis Treatment IPN, New Delhi can facilitate patient to import of "DUPIXENT (dupilumab) injection" in quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).

Health Professional In India If you have any question, please email IPN Support Team or Call Indian Pharma Network for DUPIXENT (dupilumab) injection price list or cost in India. on
Mr. Tarun:- +91 9891 296 838
Mr. Neeraj:- +91 9811 747 774

DUPIXENT (dupilumab) injectioninjection price in India UK

DUPIXENT is an interleukin-4 receptor alpha antagonist indicated for the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids. DUPIXENT (dupilumab) Injection is a clear to slightly opalescent, colorless to pale yellow solution, supplied in single-dose pre-filled syringes with or without needle shield. Each pre-filled syringe with or without needle shield is designed to deliver 300 mg of DUPIXENT in 2 mL solution.

Source content : www.accessdata.fda.gov

IPN, New Delhi can facilitate patient to import of "DUPIXENT (dupilumab) injection" in quantities for personal use. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Visakhapatnam, Surat, Jaipur, Coimbatore, Kanpur, Nagpur, Raipur, Kochi, Kozhikode, Nashik, Salem, Thiruvananthapuram, Madurai, Jodhpur, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. with over 20 years of domain experience.

For procurement cost of DUPIXENT (dupilumab) injection in India, Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the DUPIXENT (dupilumab) injection medicine cost price in India.

The order for DUPIXENT (dupilumab) injection will be confirmed only after
1. submitting Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
2. Permission from obtained from the office of the Drugs Controller General (India).
3. Availability of DUPIXENT (dupilumab) injection from authorised distributor.

Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis. It is also used for the treatment of eosinophilic esophagitis and prurigo nodularis. Dupilumab is indicated for the treatment of moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP). In May 2022, the indication for dupilumab was updated to include the treatment of eosinophilic esophagitis in people aged twelve years of age and older weighing at least 40 kilograms (88 lb). In September 2022, the indication for dupilumab was updated to include the treatment of adults with prurigo nodularis (PN).

DUPIXENT (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017

• Injection: 300 mg/2 mL solution in a single-dose pre-filled syringe with needle shield
• Injection: 300 mg/2 mL solution in a single-dose pre-filled syringe

For DUPIXENT Supplied/Storage and Handling please go through For highlights of prescribing information.

For DUPIXENT Description, please go through For highlights of prescribing information.

For DUPIXENT ingredients, please go through For highlights of prescribing information.

Instructions for Preparation and Administration, please go through For highlights of prescribing information.

Yes, In November 2017, the U.S. Food and Drug Administration (FDA) approved dupilumab.

For DUPIXENT (dupilumab) injectionIndications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA Approves DUPIXENT (Dupilumab) for the Treatment of Adult Patients with Moderate-To-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled with Topical Prescription Therapies or when Those Therapies are Not Advisable For More Details

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prurigo Nodularis For More Details

FDA approves first treatment for prurigo nodularis For More Details

Step 1. Send a request for your medicine online:- Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).

Step 2. Verification of documents:- We verify your a prescription and necessary documents to import drugs in quantities for personal use.

Step 3. Permission to Import:- After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.

Step 4. We source your medicine:- Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 5. Delivery of medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Doctor’s Prescription –
We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find out -
DUPIXENT (dupilumab) injection price in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
DUPIXENT (dupilumab) injection price in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
DUPIXENT (dupilumab) injection price in North America – Mexico.
DUPIXENT (dupilumab) injection price in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
DUPIXENT (dupilumab) injection price in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
DUPIXENT (dupilumab) injection price in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
DUPIXENT (dupilumab) injection price in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
DUPIXENT (dupilumab) injection price in Australia and New Zealand.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

Get Access To DUPIXENT (dupilumab) injection In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in Hodgkin atopic dermatitis (eczema) treatment. Brand Name "DUPIXENT (dupilumab) injection" or Generic Name "dupilumab for injection" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.